22895089|t|Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
22895089|a|Precisely how the accumulation of PrP (Sc) causes the neuronal degeneration that leads to the clinical symptoms of prion diseases is poorly understood. Our recent paper showed that the clustering of specific glycosylphosphatidylinositol (GPI) anchors attached to PrP proteins triggered synapse damage in cultured neurons. First, we demonstrated that small, soluble PrP (Sc) oligomers caused synapse damage via a GPI-dependent process. Our hypothesis, that the clustering of specific GPIs caused synapse damage, was supported by observations that cross-linkage of PrP (C), either chemically or by monoclonal antibodies, also triggered synapse damage. Synapse damage was preceded by an increase in the cholesterol content of synapses and activation of cytoplasmic phospholipase A 2 (cPLA 2). The presence of a terminal sialic acid moiety, a rare modification of mammalian GPI anchors, was essential in the activation of cPLA 2 and synapse damage induced by cross-linked PrP (C). We conclude that the sialic acid modifies local membrane microenvironments (rafts) surrounding clustered PrP molecules resulting in aberrant activation of cPLA 2 and synapse damage. A recent observation, that toxic amyloid-beta assemblies cross-link PrP (C), suggests that synapse damage in prion and Alzheimer diseases is mediated via a common molecular mechanism, and raises the possibility that the pharmacological modification of GPI anchors might constitute a novel therapeutic approach to these diseases.
22895089	25	53	glycosylphosphatidylinositol	Chemical	MESH:D017261
22895089	71	74	PrP	Gene	5621
22895089	109	126	phospholipase A 2	Gene	5319
22895089	131	145	synapse damage	Disease	MESH:D020263
22895089	201	222	neuronal degeneration	Disease	MESH:D009410
22895089	262	276	prion diseases	Disease	MESH:D017096
22895089	355	383	glycosylphosphatidylinositol	Chemical	MESH:D017261
22895089	385	388	GPI	Chemical	MESH:D017261
22895089	410	413	PrP	Gene	5621
22895089	433	447	synapse damage	Disease	MESH:D020263
22895089	538	552	synapse damage	Disease	MESH:D020263
22895089	559	562	GPI	Chemical	MESH:D017261
22895089	642	656	synapse damage	Disease	MESH:D020263
22895089	710	717	PrP (C)	Gene	5621
22895089	781	795	synapse damage	Disease	MESH:D020263
22895089	797	811	Synapse damage	Disease	MESH:D020263
22895089	847	858	cholesterol	Chemical	MESH:D002784
22895089	909	926	phospholipase A 2	Gene	5319
22895089	928	934	cPLA 2	Gene	5321
22895089	964	975	sialic acid	Chemical	MESH:D019158
22895089	1017	1020	GPI	Chemical	MESH:D017261
22895089	1065	1071	cPLA 2	Gene	5321
22895089	1076	1090	synapse damage	Disease	MESH:D020263
22895089	1115	1122	PrP (C)	Gene	5621
22895089	1145	1156	sialic acid	Chemical	MESH:D019158
22895089	1229	1232	PrP	Gene	5621
22895089	1279	1285	cPLA 2	Gene	5321
22895089	1290	1304	synapse damage	Disease	MESH:D020263
22895089	1339	1351	amyloid-beta	Gene	351
22895089	1374	1381	PrP (C)	Gene	5621
22895089	1397	1411	synapse damage	Disease	MESH:D020263
22895089	1415	1420	prion	Disease	MESH:D017096
22895089	1425	1443	Alzheimer diseases	Disease	MESH:D000544
22895089	1558	1561	GPI	Chemical	MESH:D017261
22895089	Association	MESH:D017261	MESH:D020263
22895089	Association	351	5621
22895089	Association	MESH:D000544	5621
22895089	Positive_Correlation	MESH:D002784	MESH:D020263
22895089	Association	MESH:D017261	5621
22895089	Association	MESH:D020263	5319
22895089	Association	MESH:D017261	5319
22895089	Positive_Correlation	5319	5621
22895089	Positive_Correlation	MESH:D020263	5621
22895089	Association	MESH:D017261	MESH:D019158
22895089	Association	MESH:D019158	5621
22895089	Association	MESH:D020263	5321
22895089	Positive_Correlation	MESH:D019158	MESH:D020263
22895089	Positive_Correlation	5321	5621
22895089	Positive_Correlation	MESH:D019158	5321

